Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Bela F Asztalos

Showing results (1-10 of 106) with videos related to

Pageof 11
Sort By:
Journal of Clinical Lipidology|December 3, 2010
High-density lipoprotein particles, coronary heart disease, and niacinBela F Asztalos
Current Opinion in Cardiology|June 26, 2004
High-density lipoprotein metabolism and progression of atherosclerosis: new insights from the HDL Atherosclerosis Treatment StudyBela F Asztalos,
Atherosclerosis. Supplements|April 26, 2003
HDL in atherosclerosis: actor or bystander?Bela F Asztalos, Ernst J Schaefer
Current Opinion in Lipidology|July 13, 2006
Cholesteryl ester transfer protein inhibition, high-density lipoprotein metabolism and heart disease risk reductionErnst J Schaefer, Bela F Asztalos
The American Journal of Cardiology|December 6, 2007
Increasing high-density lipoprotein cholesterol, inhibition of cholesteryl ester transfer protein, and heart disease risk reductionErnst J Schaefer, Bela F Asztalos
Current Atherosclerosis Reports|February 4, 2006
The effects of statins on high-density lipoproteinsErnst J Schaefer, Bela F Asztalos
The American Journal of Cardiology|April 8, 2003
High-density lipoprotein subpopulations in pathologic conditionsBela F Asztalos, Ernst J Schaefer
Nature Clinical Practice. Endocrinology & Metabolism|August 26, 2006
Should we target HDL-cholesterol to reduce coronary heart disease risk?Ernst J Schaefer, Bela F Asztalos
Current Opinion in Cardiology|June 9, 2007
Where are we with high-density lipoprotein raising and inhibition of cholesteryl ester transfer for heart disease risk reduction?Ernst J Schaefer, Bela F Asztalos
Current Opinion in Lipidology|May 31, 2018
Where next with HDL assays?Katrin Niisuke, Katalin V Horvath, Bela F Asztalos
Pageof 11

Showing results (1-10 of 106) with videos related to

Sort By:
Pageof 11
Journal of Clinical Lipidology|December 3, 2010
High-density lipoprotein particles, coronary heart disease, and niacinBela F Asztalos
Current Opinion in Cardiology|June 26, 2004
High-density lipoprotein metabolism and progression of atherosclerosis: new insights from the HDL Atherosclerosis Treatment StudyBela F Asztalos,
Atherosclerosis. Supplements|April 26, 2003
HDL in atherosclerosis: actor or bystander?Bela F Asztalos, Ernst J Schaefer
Current Opinion in Lipidology|July 13, 2006
Cholesteryl ester transfer protein inhibition, high-density lipoprotein metabolism and heart disease risk reductionErnst J Schaefer, Bela F Asztalos
The American Journal of Cardiology|December 6, 2007
Increasing high-density lipoprotein cholesterol, inhibition of cholesteryl ester transfer protein, and heart disease risk reductionErnst J Schaefer, Bela F Asztalos
Current Atherosclerosis Reports|February 4, 2006
The effects of statins on high-density lipoproteinsErnst J Schaefer, Bela F Asztalos
The American Journal of Cardiology|April 8, 2003
High-density lipoprotein subpopulations in pathologic conditionsBela F Asztalos, Ernst J Schaefer
Nature Clinical Practice. Endocrinology & Metabolism|August 26, 2006
Should we target HDL-cholesterol to reduce coronary heart disease risk?Ernst J Schaefer, Bela F Asztalos
Current Opinion in Cardiology|June 9, 2007
Where are we with high-density lipoprotein raising and inhibition of cholesteryl ester transfer for heart disease risk reduction?Ernst J Schaefer, Bela F Asztalos
Current Opinion in Lipidology|May 31, 2018
Where next with HDL assays?Katrin Niisuke, Katalin V Horvath, Bela F Asztalos
Pageof 11